Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 5/20 | 0.56 |
| ▸ | CES1 | P23141 | 5/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28019637 | 0.97 | CES2 (0.54) | CES2CES1ESR1PTGS2L3MBTL1 | |
| SCHEMBL3191159 | 0.85 | PTGS2 (0.61) | CES2CES1ESR1PTGS2ATM | |
| SCHEMBL968382 | 0.83 | CES2 (0.60) | CES2CES1ESR1PTGS2L3MBTL1 | |
| SCHEMBL8110239 | 0.83 | L3MBTL1 (0.46) | CES2CES1L3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL9008382 | 0.81 | CES2 (0.61) | CES2CES1PTGS2L3MBTL1LMNA | |
| SCHEMBL4185181 | 0.81 | CES2 (0.61) | CES2CES1PTGS2L3MBTL1LMNA | |
| SCHEMBL21409666 | 0.81 | CES2 (0.58) | CES2CES1ESR1PTGS2L3MBTL1 | |
| SCHEMBL98487 | 0.81 | CES2 (0.61) | CES2CES1PTGS2L3MBTL1LMNA | |
| SCHEMBL98640 | 0.81 | CES2 (0.61) | CES2CES1PTGS2L3MBTL1LMNA | |
| SCHEMBL98397 | 0.81 | CES2 (0.61) | CES2CES1PTGS2L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271578-A | Polymer with phosphonic acid structure in side chain, synthesis method and application thereof in high-temperature proton exchange membrane fuel cell | 中国科学院山西煤炭化学研究所 | 2024-07-02 | — | — | CN | claimed |
| CN-110504378-A | A kind of whole soln method flexible white light device and preparation method thereof combined based on organic material and perovskite material | UNIV ELECTRONIC SCI & TECH CHINA | 2019-11-26 | — | — | CN | claimed |
| CN-106981570-B | A kind of fast preparation method and its application of perovskite thin film | PEKING UNIVERSITY (CN) | 2019-11-01 | — | — | CN | claimed |
| CN-106910828-B | A kind of solar battery and preparation method thereof with Double Perovskite membrane structure | 华南师范大学 | 2019-10-11 | — | — | CN | claimed |
| CN-107591484-B | A kind of multiplication type organic photodetector having both narrowband and broadband light detectivity | 北京交通大学 | 2019-09-24 | — | — | CN | claimed |
| CN-110212102-A | Light emitting diode with quantum dots, preparation method and display device | 京东方科技集团股份有限公司 | 2019-09-06 | — | — | CN | claimed |
| CN-107946484-B | A kind of white light organic electroluminescent device and preparation method thereof | 吉林大学 | 2019-07-26 | — | — | CN | claimed |
| CN-108767125-B | A kind of QD-3D-QD luminescent layer perovskite light emitting diode and preparation method thereof | 电子科技大学 | 2019-07-05 | — | — | CN | claimed |
| CN-109920924-A | A kind of two dimension perovskite material, luminescent layer, LED component and preparation method thereof | 香港中文大学（深圳） | 2019-06-21 | — | — | CN | claimed |
| CN-109912458-A | Metal halide perovskite material, preparation method and solar cell device and preparation method thereof | 苏州大学 | 2019-06-21 | — | — | CN | claimed |
| US-20070043046-A1 | Biaromatic ligand activators of PPARGAMMA receptors | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2007-02-22 | — | — | US | claimed |
| US-7122564-B2 | Biaromatic ligand activators of PPARγ receptors | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2006-10-17 | — | — | US | claimed |
| EP-1458697-B1 | BIPHENYLMETHYL-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE AS PPAR-GAMMA ACTIVATORS | GALDERMA RES & DEV (FR) | 2006-09-06 | — | — | EP | claimed |
| US-20050137238-A1 | Biaromatic ligand activators of PPARgamma receptors | GALDERMA RESEARCH & DEVELOPMENT S.N.C. | 2005-06-23 | — | — | US | claimed |
| US-6908939-B2 | Biaromatic ligand activators of PPARγ receptors | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2005-06-21 | — | — | US | claimed |
| EP-1458697-A1 | BIPHENYLMETHYL-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE AS PPAR-GAMMA ACTIVATORS | Galderma Research & Development, S.N.C. (FR) | 2004-09-22 | — | — | EP | claimed |
| US-20030134885-A1 | Biaromatic ligand activators of PPARgamma receptors | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2003-07-17 | — | — | US | claimed |
| WO-2003055867-A1 | BIPHENYLMETHYL-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE AS PPAR-GAMMA ACTIVATORS | GALDERMA RESEARCH & DEVELOPMENT, SNC (FR) | 2003-07-10 | — | — | WO | claimed |
| US-5288905-A | Glycyl urea derivatives as anti-convulsants | G. D. SEARLE & CO. (US) | 1994-02-22 | — | — | US | claimed |
| EP-0168626-A1 | Composition for the manufacture of a medicament for the therapeutic treatment of trauma of the skin | BAR-ILAN UNIVERSITY (IL) | 1986-01-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043046-A1 | Biaromatic ligand activators of PPARGAMMA receptors | PPARG, PPARA, PPARD | CES2 2615/4885CES1 436/4885ESR1 168/4885 |
| US-20050137238-A1 | Biaromatic ligand activators of PPARgamma receptors | PPARG, PPARA, PPARD | CES2 2615/4885CES1 436/4885ESR1 168/4885 |
| US-20030134885-A1 | Biaromatic ligand activators of PPARgamma receptors | PPARG, PPARA, PPARD | CES2 2598/4885CES1 280/4885ESR1 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.